Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 Feb;9(2):312-9.
doi: 10.1111/j.1538-7836.2010.04126.x.

Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies

W Saber  1 , T Moua, E C Williams, M Verso, G Agnelli, S Couban, A Young, M De Cicco, R Biffi, C J van Rooden, M V Huisman, D Fagnani, C Cimminiello, M Moia, M Magagnoli, S P Povoski, S F Malak, A Y Lee
Affiliations
Meta-Analysis

Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies

W Saber et al. J Thromb Haemost. 2011 Feb.

Abstract

Background: Knowledge of independent, baseline risk factors for catheter-related thrombosis (CRT) may help select adult cancer patients who are at high risk to receive thromboprophylaxis.

Objectives: We conducted a meta-analysis of individual patient-level data to identify these baseline risk factors.

Patients/methods: MEDLINE, EMBASE, CINAHL, CENTRAL, DARE and the Grey literature databases were searched in all languages from 1995 to 2008. Prospective studies and randomized controlled trials (RCTs) were eligible. Studies were included if original patient-level data were provided by the investigators and if CRT was objectively confirmed with valid imaging. Multivariate logistic regression analysis of 17 prespecified baseline characteristics was conducted. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated.

Results: A total sample of 5636 subjects from five RCTs and seven prospective studies was included in the analysis. Among these subjects, 425 CRT events were observed. In multivariate logistic regression, the use of implanted ports as compared with peripherally implanted central venous catheters (PICCs), decreased CRT risk (OR, 0.43; 95% CI, 0.23-0.80), whereas past history of deep vein thrombosis (DVT) (OR, 2.03; 95% CI, 1.05-3.92), subclavian venipuncture insertion technique (OR, 2.16; 95% CI, 1.07-4.34) and improper catheter tip location (OR, 1.92; 95% CI, 1.22-3.02), increased CRT risk.

Conclusions: CRT risk is increased with use of PICCs, previous history of DVT, subclavian venipuncture insertion technique and improper positioning of the catheter tip. These factors may be useful for risk stratifying patients to select those for thromboprophylaxis. Prospective studies are needed to validate these findings.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of studies that were identified by our search.
Figure 2
Figure 2
Freedom from CRT
See this image and copyright information in PMC

References

    1. Rosovsky RP, Kuter DJ. Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis, and management. Hematol Oncol Clin North Am. 2005;19:183–202. vii. S0889-8588(04)00116-9 [pii] 10.1016/j.hoc.2004.09.007. - PubMed
    1. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348:1123–33. 10.1056/NEJMra011883 348/12/1123 [pii] - PubMed
    1. Povoski SP. Long-term venous access. In Cancer Management: A Multidisciplinary Approach. Medical, Surgical, and Radiation Oncology. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, editors. 11th edn CMP Medica (United Business Media); Lawrence: 2008. pp. 969–80.
    1. Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, Macleod D, Burton E, Andreou P, Anderson DR. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol. 2005;23:4063–9. JCO.2005.10.192 [pii] 10.1200/JCO.2005.10.192. - PubMed
    1. Karthaus M, Kretzschmar A, Kroning H, Biakhov M, Irwin D, Marschner N, Slabber C, Fountzilas G, Garin A, Abecasis NG, Baronius W, Steger GG, Sudhoff T, Giorgetti C, Reichardt P. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol. 2006;17:289–96. mdj059 [pii]10.1093/annonc/mdj059. - PubMed

Publication types